Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Kaufman Rossin Fund Services appoints Harrison Blase as senior operations manager

Friday, November 30, 2012
Opalesque Industry Update: Kaufman Rossin Fund Services (KRFS), a top-rated fund administrator, today announced that Harrison Blase has joined the company as part of their strategic growth strategy.

Mr. Blase will be based in the KRFS Dallas office and in his new capacity will oversee operational best practices both internally and for the firm’s clients. Blase will work closely with James Davis, head of the Dallas office, in providing administration solutions to KRFS’ expanding Southwest client base.

Before joining KRFS, Blase was a founding partner and COO at Blue River Partners. Prior to founding Blue River, Mr. Blase was the Controller at Swank Capital and prior to that he was with Rothstein Kass & Company.

"We’re very excited to welcome Harrison to the KRFS family. He brings with him a deep understanding of the complexity surrounding the operational issues affecting fund managers," said Jorge R. de Cardenas, co-founder and Director of KRFS. "We've been searching for a candidate with Harrison’s skills and enthusiasm for some time and are fortunate he has chosen to be a part of the KRFS team."

KRFS

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its